The global tissue plasminogen activator market is primarily engaged in the manufacturing and development of biotechnology drugs required for the treatment of thrombotic conditions such as myocardial infarction, deep vein thrombosis, and pulmonary embolism. Tissue plasminogen activator or tPA helps in dissolving blood clots by converting plasminogen into plasmin, a proteolytic enzyme. It has...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian